DeepVerge plc

DeepVerge plc is an innovative environmental and life science company that develops and applies artificial intelligence (AI) and the Internet of Things (IoT) to analytical instrumentation. This technology enables the precise analysis and identification of bacteria, viruses, and toxins. The company's offerings include Labskin, a proprietary, lab-cultivated, full-thickness human skin model widely used for product research and development in the cosmetic, personal care, medical device, and pharmaceutical industries. They also provide Rinocloud, a data infrastructure-as-a-service that ensures secure intelligent storage, sharing, searching, encryption, and robust infrastructure. The Skin Trust Club allows for skin health tracking, utilizing advanced sequencing, bioinformatics, and AI algorithms. DeepVerge further delivers regulated environmental toxicology services and offers a human skin equivalent platform to validate the safety and efficacy of client products for regulatory approval. An AI and microbiome platform supports clinical trials for skincare companies and provides remote consumer skin test kits. Additionally, a sophisticated monitoring and data analytics platform is available for the real-time detection and identification of pathogens in various water systems, including treatment plants, drinking water, rivers, lakes, and reservoirs. The company also markets its own line of skincare products and cannabinoid oils. Operating across the United Kingdom, continental Europe, the United States, and other international markets, DeepVerge plc was established in 2016. It changed its name from Integumen Plc to DeepVerge plc in October 2020 and maintains its headquarters in Malahide, Ireland.

DeepVerge plc trades as DVRG.L on LSE. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in GBP.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £9.30M of revenue and -£2.68M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

DeepVerge plc can be compared against peers such as Deltex Medical Group plc, Hellenic Dynamics Plc, IQ-AI Limited, Kanabo Group Plc, LungLife AI, Inc., LungLife AI, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £1.16M, beta of 1.07, and return on equity of -11.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

DVRG.L currently shows total debt of £2.28M and beta of 1.07. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.deepverge.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.